Daily Ards Research Analysis
Analyzed 3 papers and selected 3 impactful papers.
Summary
Today’s top ARDS-related research spans translational mechanisms and care delivery. A Nature Communications study identifies macrophage ferritin heavy chain (FTH1) as a modulator of ferroptosis and lung injury in experimental ARDS, suggesting a therapeutic target. A feasibility RCT supports multidisciplinary telemedicine clinics for post-ICU recovery in sepsis/ARDS survivors, while a neonatal cohort links post-feed SMA Doppler shifts with feeding intolerance but shows limited predictive utility.
Research Themes
- Macrophage iron metabolism and ferroptosis in ARDS
- Telemedicine models for post-ICU recovery (PICS)
- Neonatal intestinal perfusion and feeding intolerance biomarkers
Selected Articles
1. Targeting macrophage ferritin heavy chain mitigates ferroptosis and lung injury in experimental acute respiratory distress syndrome.
Human ARDS samples showed elevated FTH1/FTL in serum, blood monocytes, and alveolar macrophages. In a murine hyperoxia acute lung injury model, targeting myeloid/macrophage FTH1 reduced ferroptosis and mitigated lung injury, linking macrophage iron handling to ARDS pathobiology.
Impact: This study reveals a mechanistic link between macrophage ferritin heavy chain and ferroptosis in ARDS and demonstrates targetable biology across human and animal systems.
Clinical Implications: Macrophage FTH1 and extracellular ferritin may serve as biomarkers and therapeutic targets in ARDS; interventions modulating iron handling and ferroptosis warrant translational development.
Key Findings
- FTH1 and FTL were enriched in serum, blood monocytes, and alveolar macrophages from individuals with ARDS.
- Findings were replicated in a murine hyperoxia-induced acute lung injury model.
- Targeting myeloid/macrophage FTH1 mitigated ferroptosis and reduced lung injury in experimental ARDS.
- Data suggest macrophages are a source of elevated extracellular ferritin in ARDS.
Methodological Strengths
- Translational design integrating human ARDS samples with in vivo murine validation
- Cell-type–specific manipulation (myeloid/macrophage-targeted FTH1) supporting causality
Limitations
- Preclinical study; therapeutic efficacy and safety not tested in humans
- Exact human sample sizes and heterogeneity are not detailed in the abstract
Future Directions: Develop pharmacologic modulators of FTH1/ferroptosis and validate biomarkers and efficacy in early-phase ARDS clinical trials.
Ferritin, composed of heavy chain (FTH1) and light chain (FTL) subunits, is a key intracellular iron storage protein, but the origin and biological role of extracellular ferritin (ex-ferritin) remain poorly understood. Elevated serum ex-ferritin is associated with worse outcomes in acute respiratory distress syndrome (ARDS). Here, we show that both FTH1 and FTL are significantly enriched in the serum, blood monocytes, and alveolar macrophages (AM) of individuals with ARDS, findings we replicate in a murine hyperoxia-induced acute lung injury model. Myeloid-specific FTH1 (Fth1
2. Multidisciplinary telemedicine intervention for ICU recovery: the TelePORT feasibility randomized trial.
In a two-site pilot RCT (n=91) enrolling ICU survivors with sepsis and/or ARDS, telemedicine post-ICU clinic visits showed feasible enrollment, retention, clinician fidelity, and favorable acceptability. Attendance was modest, and exploratory 6-month composite PICS outcomes did not differ between groups.
Impact: Establishes feasibility metrics for a scalable, multidisciplinary telemedicine model to address PICS in sepsis/ARDS survivors, informing the design of definitive trials.
Clinical Implications: Telemedicine post-ICU clinics can be implemented with high clinician fidelity but need improved engagement strategies; effectiveness on long-term outcomes remains unproven.
Key Findings
- Randomized 91 ICU survivors (telemedicine n=46; standard care n=45) with sepsis and/or ARDS.
- Telemedicine attendance was 55% at 3 weeks and 42.5% at 3 months; 6-month assessments were completed by 67% in both groups.
- Clinician participation fidelity was high, and participants rated acceptability, appropriateness, and feasibility favorably.
- Exploratory composite cognitive, mental health, and physical outcomes at 6 months did not differ significantly between groups.
Methodological Strengths
- Randomized controlled design with trial registration (NCT03926533)
- Multisite implementation with standardized multidisciplinary telemedicine protocol
Limitations
- Pilot feasibility trial underpowered for efficacy; attendance and engagement were modest
- Limited diversity (91% White) may constrain generalizability
Future Directions: Design adequately powered, inclusive RCTs to test clinical effectiveness and cost-effectiveness; evaluate strategies to enhance engagement and address disparities.
BACKGROUND: Survivors of critical illness commonly experience post-intensive care syndrome (PICS), including cognitive, mental health, physical, quality-of-life, and social impairments after discharge. Telemedicine may improve access to post-ICU recovery clinic care, but its feasibility and effect on recovery outcomes remain unclear. We evaluated the feasibility of a multidisciplinary telemedicine post-ICU recovery clinic and collecting 6-month outcome data. METHODS: We conducted a two-site pilot feasibility randomized controlled trial at an academic medical center and regional community medical center in the southeas
3. Superior mesenteric artery Doppler after first feed and its association with feed intolerance and necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study.
Among 50 VLBW neonates, post-feed SMA resistive index declined significantly, but Doppler parameters were not independently associated with time to full feeds. Feed intolerance correlated with lower post-feed PI/RI and greater RI drop, showing only modest discrimination; RDS and hsPDA were stronger determinants of feeding progression.
Impact: Provides prospective data on early intestinal perfusion metrics and feeding outcomes in VLBW neonates, clarifying the limited standalone predictive value of SMA Doppler.
Clinical Implications: SMA Doppler after first feed may inform risk of feeding intolerance but should not be used in isolation; systemic illnesses (RDS, hsPDA) and management decisions more strongly drive feeding progression.
Key Findings
- Post-feed SMA resistive index decreased significantly (0.76 to 0.68; P=0.01).
- SMA Doppler parameters were not independently associated with time to full enteral feeds after adjustment.
- Neonates with feed intolerance had lower post-feed PI and RI and a greater fall in RI; ROC discrimination was modest (AUC 0.69).
- Differences in Doppler parameters among NEC cases were not statistically significant; exploratory model AUC was 0.72.
Methodological Strengths
- Prospective cohort with standardized Doppler protocols and pre/post measurements
- Adjusted analyses with Kaplan–Meier and ROC evaluation
Limitations
- Single-center, small sample size limits precision and generalizability
- Clinical management factors (e.g., feed withholding) may confound associations; limited predictive value of Doppler alone
Future Directions: Validate findings in larger, multicenter cohorts and integrate SMA Doppler with clinical and biochemical markers to build robust predictive models.
To evaluate the association of superior mesenteric artery (SMA) Doppler parameters after the first feed with feed intolerance and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) neonates. This prospective cohort study was conducted in a tertiary neonatal intensive care unit from July 2024 to January 2025. VLBW neonates underwent SMA Doppler assessment before and 60 min after the first feed using standardized protocols. The primary outcome was time to full enteral feeds; secondary outcomes included feed intolerance, NEC, and sepsis. Fifty neonates were included. Post-feed resistive index (RI) decreased significantly (0.76-0.68; P = .01). On adjusted analysis, SMA Doppler parameters were not independently associated with time to full feeds, while respiratory distress syndrome (RDS) and hemodynamically significant patent ductus arteriosus (hsPDA) were significantly associated. Median time to full feeds was 9 days on Kaplan-Meier analysis. Neonates with feed intolerance had lower post-feed pulsatility index (PI) and RI, and a greater fall in RI. ROC analysis showed modest discrimination (AUC 0.69, 95% CI 0.53-0.84). Doppler differences in neonates with NEC were not statistically significant; an exploratory model showed modest discrimination (AUC 0.72, 95% CI 0.50-0.87). SMA Doppler parameters show possible association with feed intolerance and NEC but have limited predictive value as standalone markers. Feeding progression appeared to be more strongly influenced by systemic illnesses such as RDS, hsPDA, and by clinical management factors including feed withholding and individualized advancement decisions.